Genetic Hair Loss Test To Be Introduced In Dominican Republic

The genetic baldness tests will be introduced to the Dominican Republic by Skin and Hair Transplant Institute of Santo Domingo

June 2009

Men and women in the Dominican Republic will soon have access to genetic tests for predicting the risk of male or female hair loss thanks to a distribution agreement announced today by pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC. (www.hairdx.com)

The genetic baldness tests will be introduced to the Dominican Republic by Skin and Hair Transplant Institute of Santo Domingo (www.albareyes.com).

The company is lead by Dr. Alba Reyes Sagiv, M.D., the first surgeon in Latin America to be accepted as “American Board Certified” in the area of hair restoration (ABHRS). She is the Dominican Republic pioneer of the most advanced hair restoration techniques.

“We’re striving to offer the most advanced services and treatments to people suffering from alopecia,” says Dr. Sagiv.

“The genetic tests made by HairDX have an extremely important role in the detection of future and present AGA in men and women. It gives important information about responsiveness to patients considering Finasteride treatment.”

HairDX’s easy to use genetic test provides an accurate and understandable genetic analysis of a man’s or woman’s likelihood of developing Androgenetic Alopecia, the most common type of hair loss.

“By expanding our global footprint, PharmaGenoma is leading the way in molecular dermatology. We’re pleased to bring the latest in genetic science to men and women in the Dominican Republic,” says Andy Goren, President & CEO of PharmaGenoma, Inc.

About HairDX, LLC

HairDX, LLC (www.hairdx.com and Twitter: HairDX) is a subsidiary of PharmaGenoma, Inc. Based in Irvine, CA, USA. HairDX is a molecular dermatology research and development company. HairDX markets the first genetic test for male and female hair loss.

The company is dedicated to the research and development of new prescription based therapies tailored to an individual's genetic make up. HairDX uses only CLIA certified laboratories (Clinical Laboratory Improvement Amendments) to perform the genetic analysis.

The HairDX test collection kit is listed with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA) as a Class I medical device.

Among HairDX leaders is William V. Murray former Division President of the Molecular Biology Division of Applied BioSystems, Inc., who formerly served in various executive leadership positions within Medtronic, Inc., Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc., Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science, Dr. Elon Pras, Director of the Institute of Human Genetics, Sheba Medical Center in Tel-HasHair Lossr, Israel, Sharon Keene, MD and President and Medical Director of Physician's Hair Institute, in Tucson, Arizona and nationally recognized for her pioneering work in the hair transplant field, and Elliott J. Stein, an intellectual property attorney and co-founder of GeePS, Inc.